Unicycive Therapeutics (UNCY) Short Interest Ratio & Short Volume → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free UNCY Stock Alerts $0.97 -0.07 (-6.73%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Unicycive Therapeutics Short Interest DataCurrent Short Volume382,900 sharesPrevious Short Volume256,800 sharesChange Vs. Previous Month+49.10%Dollar Volume Sold Short$436,506.00Short Interest Ratio / Days to Cover1.0Last Record DateApril 15, 2024Outstanding Shares34,760,000 sharesFloat Size24,990,000 sharesShort Percent of Float1.53%Today's Trading Volume498,047 sharesAverage Trading Volume382,249 sharesToday's Volume Vs. Average130% Short Selling Unicycive Therapeutics ? Sign up to receive the latest short interest report for Unicycive Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatUNCY Short Interest Over TimeUNCY Days to Cover Over TimeUNCY Percentage of Float Shorted Over Time Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 Unicycive Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024382,900 shares $436,506.00 +49.1%1.5%1 $1.14 3/31/2024256,800 shares $354,384.00 +352.9%1.0%0.7 $1.38 3/15/202456,700 shares $82,782.00 +62.0%0.2%0.2 $1.46 2/29/202435,000 shares $48,300.00 -64.3%0.1%0.1 $1.38 2/15/202498,000 shares $128,380.00 +46.7%0.4%0.4 $1.31 1/31/202466,800 shares $63,460.00 -2.8%0.3%0.3 $0.95 Get the Latest News and Ratings for UNCY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Unicycive Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/202468,700 shares $57,708.00 -20.9%0.3%0.4 $0.84 12/31/202386,900 shares $75,403.13 +1.5%N/A0 $0.87 12/15/202385,600 shares $48,988.88 +65.6%0.3%0.9 $0.57 11/30/202351,700 shares $26,496.25 -30.0%0.2%0.7 $0.51 11/15/202373,900 shares $38,620.14 +18.6%0.3%1.4 $0.52 10/31/202362,300 shares $35,529.69 -42.7%0.3%1.2 $0.57 10/15/2023108,800 shares $93,350.40 -25.4%0.4%1.9 $0.86 9/30/2023145,800 shares $125,388.00 +34.5%0.6%2.4 $0.86 9/15/2023108,400 shares $75,045.32 +71.3%0.4%1.1 $0.69 8/31/202363,300 shares $48,291.57 -21.0%0.5%0.6 $0.76 8/15/202380,100 shares $60,876.00 -53.9%0.6%0.6 $0.76 7/31/2023173,800 shares $203,346.00 -16.0%3.2%1.1 $1.17 7/15/2023206,900 shares $254,487.00 -15.8%3.8%1 $1.23 6/30/2023245,800 shares $314,624.00 -10.3%2.7%1 $1.28 6/15/2023274,100 shares $433,078.00 +8.8%3.0%0.9 $1.58 5/31/2023252,000 shares $332,640.00 -13.6%2.7%0.1 $1.32 5/15/2023291,800 shares $417,274.00 +21.7%3.2%0.1 $1.43 4/30/2023239,700 shares $311,610.00 -8.0%2.6%0 $1.30 4/15/2023260,400 shares $460,908.00 -34.7%2.9%0 $1.77 3/31/2023398,700 shares $837,270.00 -71.3%4.4%0.1 $2.10 3/15/20231,390,000 shares $3.07 million +839.2%15.3%0.2 $2.21 2/28/2023148,000 shares $76,516.00 -17.9%1.6%0 $0.52 2/15/2023180,300 shares $100,968.00 +55.3%2.0%0.6 $0.56 1/31/2023116,100 shares $65,016.00 -40.6%1.3%0.4 $0.56 1/15/2023195,600 shares $97,311.00 -24.5%2.2%0.8 $0.50 12/30/2022259,000 shares $139,860.00 +284.3%2.9%1.1 $0.54 12/15/202267,400 shares $47,510.26 +18.5%0.7%2 $0.70 11/30/202256,900 shares $40,524.18 +4.8%0.6%2 $0.71 11/15/202254,300 shares $38,010.00 +35.8%0.6%2 $0.70 10/31/202240,000 shares $27,600.00 -7.4%0.4%1.6 $0.69 10/15/202243,200 shares $24,619.68 +7.2%0.5%1.3 $0.57 9/30/202240,300 shares $23,777.00 +53.2%0.4%1.2 $0.59 9/15/202226,300 shares $19,988.00 -36.0%0.3%0.8 $0.76 8/31/202241,100 shares $28,770.00 +21.2%0.5%1.2 $0.70Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. UNCY Short Interest - Frequently Asked Questions What is Unicycive Therapeutics' current short interest? Short interest is the volume of Unicycive Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 382,900 shares of UNCY short. 1.53% of Unicycive Therapeutics' shares are currently sold short. Learn More on Unicycive Therapeutics' current short interest. What is a good short interest ratio for Unicycive Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. UNCY shares currently have a short interest ratio of 1.0. Learn More on Unicycive Therapeutics's short interest ratio. What is a good short interest percentage for Unicycive Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.53% of Unicycive Therapeutics' floating shares are currently sold short. Is Unicycive Therapeutics' short interest increasing or decreasing? Unicycive Therapeutics saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 382,900 shares, an increase of 49.1% from the previous total of 256,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Unicycive Therapeutics' float size? Unicycive Therapeutics currently has issued a total of 34,760,000 shares. Some of Unicycive Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Unicycive Therapeutics currently has a public float of 24,990,000 shares. How does Unicycive Therapeutics' short interest compare to its competitors? 1.53% of Unicycive Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Unicycive Therapeutics: BriaCell Therapeutics Corp. (4.88%), Xilio Therapeutics, Inc. (4.35%), Ocuphire Pharma, Inc. (6.37%), Cara Therapeutics, Inc. (5.62%), JanOne Inc. (1.72%), ProMIS Neurosciences, Inc. (0.16%), Marker Therapeutics, Inc. (1.00%), Fortress Biotech, Inc. (13.02%), Viracta Therapeutics, Inc. (2.50%), VYNE Therapeutics Inc. (0.80%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Unicycive Therapeutics stock? Short selling UNCY is an investing strategy that aims to generate trading profit from Unicycive Therapeutics as its price is falling. UNCY shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Unicycive Therapeutics? A short squeeze for Unicycive Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of UNCY, which in turn drives the price of the stock up even further. How often is Unicycive Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including UNCY, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: BriaCell Therapeutics Short Interest Xilio Therapeutics Short Interest Ocuphire Pharma Short Interest Cara Therapeutics Short Interest JanOne Short Interest ProMIS Neurosciences Short Interest Marker Therapeutics Short Interest Fortress Biotech Short Interest Viracta Therapeutics Short Interest VYNE Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:UNCY) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press